These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 19903243)
61. Could ryanodine receptor dysfunction be linked to PKR brain accumulations in Alzheimer's disease? Hugon J; Paquet C Med Hypotheses; 2018 Apr; 113():45. PubMed ID: 29523292 [No Abstract] [Full Text] [Related]
62. Enhancing calmodulin binding to ryanodine receptor is crucial to limit neuronal cell loss in Alzheimer disease. Nakamura Y; Yamamoto T; Xu X; Kobayashi S; Tanaka S; Tamitani M; Saito T; Saido TC; Yano M Sci Rep; 2021 Mar; 11(1):7289. PubMed ID: 33790404 [TBL] [Abstract][Full Text] [Related]
63. beta-Amyloid protein amplifies calcium signalling in central neurons from the adult mouse. Hartmann H; Eckert A; Müller WE Biochem Biophys Res Commun; 1993 Aug; 194(3):1216-20. PubMed ID: 8352778 [TBL] [Abstract][Full Text] [Related]
64. Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice. Stutzmann GE; Smith I; Caccamo A; Oddo S; Laferla FM; Parker I J Neurosci; 2006 May; 26(19):5180-9. PubMed ID: 16687509 [TBL] [Abstract][Full Text] [Related]
65. RyR2-dependent modulation of neuronal hyperactivity: A potential therapeutic target for treating Alzheimer's disease. Yao J; Chen SRW J Physiol; 2024 Apr; 602(8):1509-1518. PubMed ID: 36866974 [TBL] [Abstract][Full Text] [Related]
66. beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease. Mattson MP; Barger SW; Cheng B; Lieberburg I; Smith-Swintosky VL; Rydel RE Trends Neurosci; 1993 Oct; 16(10):409-14. PubMed ID: 7504356 [TBL] [Abstract][Full Text] [Related]
67. The Role of Ryanodine Receptors in Regulating Neuronal Activity and Its Connection to the Development of Alzheimer's Disease. Chiantia G; Hidisoglu E; Marcantoni A Cells; 2023 Apr; 12(9):. PubMed ID: 37174636 [TBL] [Abstract][Full Text] [Related]
68. Reduced tissue levels of noradrenaline are associated with behavioral phenotypes of the TgCRND8 mouse model of Alzheimer's disease. Francis BM; Yang J; Hajderi E; Brown ME; Michalski B; McLaurin J; Fahnestock M; Mount HT Neuropsychopharmacology; 2012 Jul; 37(8):1934-44. PubMed ID: 22491352 [TBL] [Abstract][Full Text] [Related]
70. Motor coordination and synaptic plasticity deficits are associated with increased cerebellar activity of NADPH oxidase, CAMKII, and PKC at preplaque stage in the TgCRND8 mouse model of Alzheimer's disease. Russo R; Cattaneo F; Lippiello P; Cristiano C; Zurlo F; Castaldo M; Irace C; Borsello T; Santamaria R; Ammendola R; Calignano A; Miniaci MC Neurobiol Aging; 2018 Aug; 68():123-133. PubMed ID: 29602494 [TBL] [Abstract][Full Text] [Related]
71. Targeting Post-Translational Remodeling of Ryanodine Receptor: A New Track for Alzheimer's Disease Therapy? Chami M; Checler F Curr Alzheimer Res; 2020; 17(4):313-323. PubMed ID: 32096743 [TBL] [Abstract][Full Text] [Related]
72. Polymorphisms Within RYR3 Gene Are Associated With Risk and Age at Onset of Hypertension, Diabetes, and Alzheimer's Disease. Gong S; Su BB; Tovar H; Mao C; Gonzalez V; Liu Y; Lu Y; Wang KS; Xu C Am J Hypertens; 2018 Jun; 31(7):818-826. PubMed ID: 29590321 [TBL] [Abstract][Full Text] [Related]
74. Generation of dendritic Ca2+ oscillations as a consequence of altered ryanodine receptor function in AD neurons. Goussakov I; Chakroborty S; Stutzmann GE Channels (Austin); 2011; 5(1):9-13. PubMed ID: 21139422 [TBL] [Abstract][Full Text] [Related]
75. The role of ryanodine receptor type 3 in a mouse model of Alzheimer disease. Liu J; Supnet C; Sun S; Zhang H; Good L; Popugaeva E; Bezprozvanny I Channels (Austin); 2014; 8(3):230-42. PubMed ID: 24476841 [TBL] [Abstract][Full Text] [Related]
76. Lymphocytes and neutrophils as peripheral models to study the effect of beta-amyloid on cellular calcium signalling in Alzheimer's disease. Eckert A; Förstl H; Zerfass R; Hartmann H; Müller WE Life Sci; 1996; 59(5-6):499-510. PubMed ID: 8761338 [TBL] [Abstract][Full Text] [Related]
77. Amyloid-β25-35 Upregulates Endogenous Neuroprotectant Neuroglobin via NFκB Activation in vitro. Liu N; Yu Z; Xun Y; Shu P; Yue Y; Yuan S; Jiang Y; Huang Z; Yang X; Feng X; Xiang S; Wang X J Alzheimers Dis; 2018; 64(4):1163-1174. PubMed ID: 30010125 [TBL] [Abstract][Full Text] [Related]
78. Deficiency of presenilin-1 increases calcium-dependent vulnerability of neurons to oxidative stress in vitro. Nakajima M; Miura M; Aosaki T; Shirasawa T J Neurochem; 2001 Aug; 78(4):807-14. PubMed ID: 11520901 [TBL] [Abstract][Full Text] [Related]
79. Dysregulation of calcium homeostasis in Alzheimer's disease. Small DH Neurochem Res; 2009 Oct; 34(10):1824-9. PubMed ID: 19337829 [TBL] [Abstract][Full Text] [Related]
80. Advancing age alters the expression of the ryanodine receptor 3 isoform in adult rat superior cervical ganglia. Vanterpool CK; Vanterpool EA; Pearce WJ; Buchholz JN J Appl Physiol (1985); 2006 Aug; 101(2):392-400. PubMed ID: 16645194 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]